搜索
Search
这是描述信息

Products

/
/
/
Active pharmaceutical ingredients
cp1
cp1

Active pharmaceutical ingredients

Product Description
Parameters
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Retail price
0.0
Market price
0.0
Number of views:
1000
Product serial number
Quantity
-
+
Stock:
1
There is currently no information to display
Please add data record on website background.

相关产品

the Recombinant SARS-COV-2 Fusion Protein Vaccine LIKANG V-01
In September 2022, the Recombinant SARS-COV-2 Fusion Protein Vaccine LIKANG V-01 developed by Livzon Mabpharm Inc. in collaboration with the Institute of Biophysics, Chinese Academy of Sciences, was proposed by the National Health Commission and approved by the National Medical Products Administration upon demonstration to be included for the emergency use as sequential booster immunization.
更多 白箭头 黑箭头
Recombinant Human Choriogonadotropin alfa for Injection
更多 白箭头 黑箭头
Tocilizumab Injection
更多 白箭头 黑箭头

在线留言

Username used for comment:
不良报告
Description:

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn